Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 890.04M P/E - EPS this Y 32.00% Ern Qtrly Grth -
Income -67.06M Forward P/E -27.19 EPS next Y -13.00% 50D Avg Chg -2.00%
Sales 4.09M PEG -0.94 EPS past 5Y - 200D Avg Chg 91.00%
Dividend N/A Price/Book 4.44 EPS next 5Y 21.70% 52W High Chg -13.00%
Recommedations 2.60 Quick Ratio 12.46 Shares Outstanding 63.29M 52W Low Chg 3,763.00%
Insider Own 2.10% ROA -18.62% Shares Float 21.92M Beta -
Inst Own 103.43% ROE -37.23% Shares Shorted/Prior 1.16M/1.74M Price 14.68
Gross Margin 100.00% Profit Margin - Avg. Volume 419,328 Target Price 28.67
Oper. Margin -48,350.94% Earnings Date - Volume 499,565 Change -2.52%
About Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California. As of March 7, 2024, Ambrx Biopharma Inc. operates as a subsidiary of Johnson & Johnson.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nelson Sonja Chief Financial Offi.. Chief Financial Officer Oct 27 Sell 9.82 12,778 125,480 130,079 10/31/23
O'Connor Daniel J. President and CEO President and CEO Oct 27 Sell 9.82 50,012 491,118 342,845 10/31/23
Cormorant Asset Management, LP 10% Owner 10% Owner Oct 23 Buy 6.9911 1,307,311 9,139,542 11,231,000 10/25/23
Cormorant Asset Management, LP 10% Owner 10% Owner Sep 15 Buy 9.15 2,152,738 19,697,553 69,465,823 09/19/23
Cormorant Asset Management, LP 10% Owner 10% Owner Apr 18 Buy 11.34 5,215,189 59,140,243 67,313,085 04/20/23
Cormorant Asset Management, LP 10% Owner 10% Owner Apr 13 Buy 9.93 2,597,896 25,797,107 62,097,896 04/17/23